J 2023

Serum matrix metalloproteinase-9 (MMP-9) as a biomarker in paediatric and adult tick-borne encephalitis patients.

FOŘTOVÁ, Andrea, Václav HÖNIG, Jiří SALÁT, Martin PALUS, Martina PÝCHOVÁ et. al.

Basic information

Original name

Serum matrix metalloproteinase-9 (MMP-9) as a biomarker in paediatric and adult tick-borne encephalitis patients.

Authors

FOŘTOVÁ, Andrea (203 Czech Republic), Václav HÖNIG (203 Czech Republic), Jiří SALÁT (203 Czech Republic), Martin PALUS (203 Czech Republic), Martina PÝCHOVÁ (203 Czech Republic, belonging to the institution), Lenka KRBKOVÁ (203 Czech Republic, belonging to the institution), Andrey V. BARKHASH, Michal F. KRIHA, Ales CHRDLE, Marie LIPOLDOVA and Daniel RŮŽEK (203 Czech Republic, guarantor, belonging to the institution)

Edition

Virus Research, Elsevier, 2023, 0168-1702

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10607 Virology

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.000 in 2022

RIV identification code

RIV/00216224:14310/23:00130311

Organization unit

Faculty of Science

UT WoS

000920459100001

Keywords in English

Tick-borne encephalitis; Neuroinfection; Matrix matalloproteinase; Cerebrospinal fluid

Tags

International impact, Reviewed
Změněno: 2/3/2023 12:35, Mgr. Marie Šípková, DiS.

Abstract

V originále

Matrix metalloproteinases (MMPs) play an important role in central nervous system infections. We analysed the levels of 8 different MMPs in the cerebrospinal fluid (CSF) of 89 adult patients infected with tick-borne encephalitis (TBE) virus and compared them with the levels in a control group. MMP-9 was the only MMP that showed significantly increased CSF levels in TBE patients. Serum MMP-9 levels were subsequently measured in 101 adult TBE patients at various time points during the neurological phase of TBE and at follow-up. In addition, serum MMP-9 was analysed in 37 paediatric TBE patients. Compared with control levels, both paediatric and adult TBE patients had significantly elevated serum MMP-9 levels. In most adult patients, serum MMP-9 levels peaked at hospital admission, with higher serum MMP-9 levels observed in patients with encephalitis than in patients with meningitis. Elevated serum MMP-9 levels were observed throughout hospitalisation but decreased to normal levels at follow-up. Serum MMP-9 levels correlated with clinical course, especially in patients heterozygous for the single-nucleotide polymorphism rs17576 (A/G; Gln279Arg) in the MMP9 gene. The results highlight the importance of MMP-9 in the pathogenesis of TBE and suggest that serum MMP-9 may serve as a promising bioindicator of TBE in both paediatric and adult TBE patients.